Long‐term recurrence (> 5 years) · patients with oesophageal cancer
It is very uncertain whether non‐surgical changes long‐term recurrence (binary outcome) Local recurrence, surgical… compared with surgical treatment of oesophageal cancer (secondary outcomes) (very low certainty).
1 finding from 1 review
Long‐term recurrence (maximal · patients with oesophageal cancer
Non‐surgical showed no clear difference in long‐term recurrence (time‐to‐event outcome) Local recurrence,… compared with surgical treatment of oesophageal cancer (secondary outcomes) (low certainty).
1 finding from 1 review
Length of hospital stay (days) Including the index admission for oesophagectomy (the hospital admission during which the oesophagectomy is performed) and any surgical complication‐related readmissions · patients with oesophageal cancer
1 finding from 1 review
Short‐term mortality All‐cause mortality either in‐hospital or within 3 months · patients with oesophageal cancer
It is very uncertain whether non‐surgical changes short‐term mortality All‐cause mortality either in‐hospital or… compared with surgical treatment of oesophageal cancer (primary outcomes) (very low certainty).
1 finding from 1 review
Local recurrence · patients with oesophageal cancer
It is very uncertain whether non‐surgical changes local recurrence (binary) compared with surgical treatment of oesophageal cancer (secondary outcomes) (very low certainty).
1 finding from 1 review
Proportion with any adverse event within 3 months Any adverse event within 3 months of any severity · patients with oesophageal cancer
It is very uncertain whether non‐surgical changes proportion with any adverse event within 3 months Any adverse event… compared with surgical treatment of oesophageal cancer (secondary outcomes) (very low certainty).
1 finding from 1 review
Dysphagia · patients with oesophageal cancer
It is very uncertain whether non‐surgical changes dysphagia at maximal compared with surgical treatment of oesophageal cancer (secondary outcomes) (very low certainty).
1 finding from 1 review
Long‐term mortality (binary outcome) All‐cause mortality for the duration of · patients with oesophageal cancer
Non‐surgical showed no clear difference in long‐term mortality (binary outcome) All‐cause mortality for the… compared with surgical treatment of oesophageal cancer (primary outcomes) (low certainty).
2 findings from 1 review
Long‐term mortality (time‐to‐event outcome): chemoradiotherapy versus surgery All‐cause mortality for the duration of · patients with oesophageal cancer
Non‐surgical showed no clear difference in long‐term mortality (time‐to‐event outcome): chemoradiotherapy… compared with surgical treatment of oesophageal cancer (primary outcomes) (low certainty).
2 findings from 1 review
Long‐term mortality (time‐to‐event outcome): radiotherapy versus surgery All‐cause mortality for the duration of · patients with oesophageal cancer
It is very uncertain whether non‐surgical changes long‐term mortality (time‐to‐event outcome): radiotherapy versus… compared with surgical treatment of oesophageal cancer (primary outcomes) (very low certainty).
1 finding from 1 review
Proportion of participants with 1 or more serious adverse events according to International Conference on Harmonisation Good Clinical Practice (ICH‐GCP) · patients with oesophageal cancer
It is very uncertain whether non‐surgical changes proportion with a serious adverse event within 3 months Serious… compared with surgical treatment of oesophageal cancer (primary outcomes) (very low certainty).
1 finding from 1 review
Health‐related quality of life Validated self‐reported measures · patients with oesophageal cancer
1 finding from 1 review
Health‐related quality of life (medium‐term) Self‐assessed questionnaires · patients with oesophageal cancer
1 finding from 1 review
Surgical relapse · people with surgically‐induced remission in Crohn's disease
It is very uncertain whether azathioprine or 6‐mercaptopurine changes surgical relapse compared with 5‐aminosalicylic acid (very low certainty).
1 finding from 1 review
Surgical relapse · people with surgically‐induced remission in Crohn's disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Surgical relapse · people with surgically‐induced remission in Crohn's disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Overall survival (OS) · patients with resectable gastric cancer
Post‐surgical chemotherapy leads to lower overall Survival (OS) compared with surgery alone (high certainty).
1 finding from 1 review
Disease-free survival · patients with resectable gastric cancer
Post‐surgical chemotherapy leads to lower disease Free Survival compared with surgery alone (high certainty).
1 finding from 1 review
Rate of surgical reintervention · adults undergoing open pancreaticoduodenectomy
It is very uncertain whether duct‐to‐mucosa pancreaticojejunostomy using the modified Blumgart… changes rate of surgical reintervention compared with duct‐to‐mucosa pancreaticojejunostomy using the traditional… (very low certainty).
1 finding from 1 review
Overall rate of surgical complications · adults undergoing open pancreaticoduodenectomy
It is very uncertain whether duct‐to‐mucosa pancreaticojejunostomy using the modified Blumgart… changes overall rate of surgical complications compared with duct‐to‐mucosa pancreaticojejunostomy using the traditional… (very low certainty).
1 finding from 1 review